Terms: = Breast cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Clinical Outcome
9 results:
1. Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy.
An M; Wang W; Zhang J; Till BG; Zhao L; Huang H; Yang Y; Li T; Han L; Zhang X; Qin P; Wang Y; Zhang M; Cui H; Gao Q; Wang Z
Cancer Immunol Immunother; 2023 Feb; 72(2):385-395. PubMed ID: 35907016
[TBL] [Abstract] [Full Text] [Related]
2. Single hormone receptor-positive breast cancer patients experienced poor survival outcomes: a systematic review and meta-analysis.
Wu N; Fu F; Chen L; Lin Y; Yang P; Wang C
Clin Transl Oncol; 2020 Apr; 22(4):474-485. PubMed ID: 31222450
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S
Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962
[TBL] [Abstract] [Full Text] [Related]
4. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO breast cancer Working Group.
Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
[TBL] [Abstract] [Full Text] [Related]
5. Aromatase in colon carcinoma.
Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Miki Y; Kamogawa Y; Yamamoto K; Takayuki ; Egawa S; Unno M; Sasano H
Anticancer Res; 2012 Aug; 32(8):3069-75. PubMed ID: 22843875
[TBL] [Abstract] [Full Text] [Related]
6. Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells.
Luciani MG; Seok J; Sayeed A; Champion S; Goodson WH; Jeffrey SS; Xiao W; Mindrinos M; Davis RW; Dairkee SH
PLoS One; 2011; 6(5):e20016. PubMed ID: 21625507
[TBL] [Abstract] [Full Text] [Related]
7. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract] [Full Text] [Related]
8. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract] [Full Text] [Related]
9. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract] [Full Text] [Related]
